{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:30:42Z","timestamp":1794047442907,"version":"4.8.0"},"reference-count":40,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"abstract":"<jats:p>Diagnostic criteria for juvenile myelomonocytic leukemia (JMML) are currently well defined, however in some patients diagnosis still remains a challenge. Flow cytometry is a well established tool for diagnosis and follow-up of hematological malignancies, nevertheless it is not routinely used for JMML diagnosis. Herewith, we characterized the CD34+ hematopoietic precursor cells collected from 31 children with JMML using a combination of standardized EuroFlow antibody panels to assess the ability to discriminate JMML cells from normal\/reactive bone marrow cell as controls (n=29) or from cells of children with other hematological diseases mimicking JMML (n=9). CD34+ precursors in JMML showed markedly reduced B-cell and erythroid-committed precursors compared to controls, whereas monocytic and CD7+ lymphoid precursors were significantly expanded. Moreover, aberrant immunophenotypes were consistently present in CD34+ precursors in JMML, while they were virtually absent in controls. Multivariate logistic regression analysis showed that combined assessment of the number of CD34+CD7+ lymphoid precursors and CD34+ aberrant precursors or erythroid precursors had a great potential in discriminating JMMLs versus controls. Importantly our scoring model allowed highly efficient discrimination of truly JMML versus patients with JMML-like diseases. In conclusion, we show for the first time that CD34+ precursors from JMML patients display a unique immunophenotypic profile which might contribute to a fast and accurate diagnosis of JMML worldwide by applying an easy to standardize single eight-color antibody combination.<\/jats:p>","DOI":"10.3324\/haematol.2023.282805","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T03:29:20Z","timestamp":1691033360000},"page":"521-532","source":"Crossref","is-referenced-by-count":3,"title":["Phenotypic profiling of CD34&lt;sup&gt;+&lt;\/sup&gt; cells by advanced flow cytometry improves diagnosis of juvenile myelomonocytic leukemia"],"prefix":"10.3324","volume":"109","author":[{"given":"Cristina","family":"Bugarin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Antolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Buracchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Matarraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana Angela","family":"Coliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent H.","family":"Van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Szczepanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine Sobral","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alita","family":"Van der Sluijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Mejstrikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana Vieira","family":"De Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aanei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"S\u0119dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Strocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sainati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Philipp\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques J.M.","family":"Van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Biondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gaipa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2023,8,3]]},"reference":[{"key":"57427","doi-asserted-by":"crossref","unstructured":"Emanuel P, Bates L, Castleberry R, Gualtieri R, Zuckerman K. Selective hypersensitivity to granulocyte-macrophage colony-stimulating factor by juvenile chronic myeloid leukemia hematopoietic progenitors. Blood. 1991; 77(5):925-929.","DOI":"10.1182\/blood.V77.5.925.bloodjournal775925"},{"key":"57428","doi-asserted-by":"crossref","unstructured":"Freedman MH, Cohen A, Grunberger T. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Br J Haematol. 1992; 80(1):40-48.","DOI":"10.1111\/j.1365-2141.1992.tb06398.x"},{"key":"57429","unstructured":"Hasle H, Kerndrup G, Jacobsen BB. Childhood myelodysplastic syndrome in Denmark: Incidence and predisposing conditions. Leukemia. 1995; 9(9):1569-1572."},{"key":"57430","unstructured":"Baumann I, Bennett JM, Niemeyer CM. Juvenile myelomonocytic leukemia. 2017;89-92."},{"key":"57431","doi-asserted-by":"crossref","unstructured":"Khoury JD, Solary E, Abla O. The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms. Leukemia. 2022; 36(7):1703-1719.","DOI":"10.1038\/s41375-022-01613-1"},{"key":"57432","doi-asserted-by":"crossref","unstructured":"Niemeyer CM, Flotho C. Juvenile myelomonocytic leukemia: who\u2019s the driver at the wheel?. Blood. 2019; 133(10):1060-1070.","DOI":"10.1182\/blood-2018-11-844688"},{"key":"57433","doi-asserted-by":"crossref","unstructured":"Castro-malaspina H, Schaison G, Passe S. Subacute and chronic myelomonocytic leukemia in children (juvenile CML). Clinical and hematologic observations, and identification of prognostic factors. Cancer. 1984; 54(4):675-686.","DOI":"10.1002\/1097-0142(1984)54:4<675::AID-CNCR2820540415>3.0.CO;2-Q"},{"key":"57434","unstructured":"Niemeyer CM, Aric\u00f3 M, Basso G. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood. 1997; 89(10):3534-3543."},{"key":"57435","doi-asserted-by":"crossref","unstructured":"Greenmyer JR, Kohorst M. Pediatric neoplasms presenting with monocytosis. Curr Hematol Malig Rep. 2021; 16(3):235-246.","DOI":"10.1007\/s11899-021-00611-x"},{"key":"57436","doi-asserted-by":"crossref","unstructured":"Murakami N, Okuno Y, Yoshida K. Integrated molecular profiling of juvenile myelomonocytic leukemia. Blood. 2018; 131(14):1576-1586.","DOI":"10.1182\/blood-2017-07-798157"},{"key":"57437","doi-asserted-by":"crossref","unstructured":"Locatelli F, Niemeyer CM. How I treat juvenile myelomonocytic leukemia. Blood. 2015; 125(7):1083-1090.","DOI":"10.1182\/blood-2014-08-550483"},{"key":"57438","doi-asserted-by":"crossref","unstructured":"Hasegawa D, Bugarin C, Giordan M. Validation of flow cytometric phospho-STAT5 as a diagnostic tool for juvenile myelomonocytic leukemia. Blood Cancer J. 2013; 3(11):e160.","DOI":"10.1038\/bcj.2013.56"},{"key":"57439","doi-asserted-by":"crossref","unstructured":"Kotecha N, Flores NJ, Irish JM. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell. 2008; 14(4):335-343.","DOI":"10.1016\/j.ccr.2008.08.014"},{"key":"57440","doi-asserted-by":"crossref","unstructured":"Olk-Batz C, Poetsch AR, N\u00f6llke P. Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome. Blood. 2011; 117(18):4871-4880.","DOI":"10.1182\/blood-2010-08-298968"},{"key":"57441","doi-asserted-by":"crossref","unstructured":"Schonung M, Meyer J, Nollke P. International consensus definition of DNA methylation subgroups in juvenile myelomonocytic leukemia. Clin Cancer Res. 2021; 27(1):158-168.","DOI":"10.1158\/1078-0432.CCR-20-3184"},{"key":"57442","doi-asserted-by":"crossref","unstructured":"Poetsch AR, Lipka DB, Witte T. RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia. Epigenetics. 2014; 9(9):1252-1260.","DOI":"10.4161\/epi.29941"},{"key":"57443","doi-asserted-by":"crossref","unstructured":"Pinkel D, Arico M, Biondi A. Differentiating juvenile myelomonocytic leukemia from infectious disease. Blood. 1998; 91(1):365-367.","DOI":"10.1182\/blood.V91.1.365.365_365_367"},{"key":"57444","doi-asserted-by":"crossref","unstructured":"Karow A, Baumann I, Niemeyer CM. Morphologic differential diagnosis of juvenile myelomonocytic leukemia-pitfalls apart from viral infection. J Pediatr Hematol Oncol. 2009; 31(5):380.","DOI":"10.1097\/MPH.0b013e31819ed260"},{"key":"57445","doi-asserted-by":"crossref","unstructured":"Yoshimi A, Kamachi Y, Imai K. Wiskott-Aldrich syndrome presenting with a clinical picture mimicking juvenile myelomonocytic leukaemia. Pediatr Blood Cancer. 2013; 60(5):836-841.","DOI":"10.1002\/pbc.24359"},{"key":"57446","doi-asserted-by":"crossref","unstructured":"Loh ML. Recent advances in the pathogenesis and treatment of juvenile myelomonocytic leukaemia. Br J Haematol. 2011; 152(6):677-687.","DOI":"10.1111\/j.1365-2141.2010.08525.x"},{"key":"57447","doi-asserted-by":"crossref","unstructured":"Chan RJ, Cooper T, Kratz CP, Weiss B, Loh ML. Juvenile myelomonocytic leukemia: a report from the 2nd International JMML Symposium. Leuk Res. 2009; 33(3):355-362.","DOI":"10.1016\/j.leukres.2008.08.022"},{"key":"57448","doi-asserted-by":"crossref","unstructured":"Locatelli F, Algeri M, Merli P, Strocchio L. Novel approaches to diagnosis and treatment of juvenile myelomonocytic leukemia. Exp Rev Hematol. 2018; 11(2):129-143.","DOI":"10.1080\/17474086.2018.1421937"},{"key":"57449","unstructured":"Gupta AK, Meena JP, Chopra A, Tanwar P, Seth R. Juvenile myelomonocytic leukemia-A comprehensive review and recent advances in management. Am J Blood Res. 2021; 11(1):1-21."},{"key":"57450","doi-asserted-by":"crossref","unstructured":"Oliveira AF, Tansini A, Toledo T. Immunophenotypic changes in juvenile myelomonocytic leukaemia after treatment with hypomethylating agent: do they help to evaluate depth of response?. Br J Haematol. 2022; 197(3):339-348.","DOI":"10.1111\/bjh.18089"},{"key":"57451","doi-asserted-by":"crossref","unstructured":"Oliveira AF, Tansini A, Vidal DO, Lopes LF, Metze K, Lorand-Metze I. Characteristics of the phenotypic abnormalities of bone marrow cells in childhood myelodysplastic syndromes and juvenile myelomonocytic leukemia. Pediatr Blood Cancer. 2017; 64(4):e26285.","DOI":"10.1002\/pbc.26285"},{"key":"57452","doi-asserted-by":"crossref","unstructured":"Frisanco Oliveira A, Tansini A, Toledo TR. Immunophenotypic characteristics of juvenile myelomonocytic leukaemia and their relation with the molecular subgroups of the disease. Br J Haematol. 2021; 192(1):129-136.","DOI":"10.1111\/bjh.17098"},{"key":"57453","doi-asserted-by":"crossref","unstructured":"Van Dongen JJM, Lhermitte L, B\u00f6ttcher S. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012; 26(9):1908-1975.","DOI":"10.1038\/leu.2012.120"},{"key":"57454","doi-asserted-by":"crossref","unstructured":"Matarraz S, Almeida J, Flores-Montero J. Introduction to the diagnosis and classification of monocytic-lineage leukemias by flow cytometry. Cytometry B Clin Cytom. 2017; 92(3):218-227.","DOI":"10.1002\/cyto.b.21219"},{"key":"57455","doi-asserted-by":"crossref","unstructured":"Kalina T, Flores-Montero J, Van Der Velden VHJ. EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols. Leukemia. 2012; 26(9):1986-2010.","DOI":"10.1038\/leu.2012.122"},{"key":"57456","doi-asserted-by":"crossref","unstructured":"Niemeyer CM. JMML genomics and decisions. Hematology Am Soc Hematol Educ Program. 2018; 2018(1):307-312.","DOI":"10.1182\/asheducation-2018.1.307"},{"key":"57457","doi-asserted-by":"crossref","unstructured":"Lhermitte L, Barreau S, Morf D. Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study. Mod Pathol. 2021; 34(1):59-69.","DOI":"10.1038\/s41379-020-00677-7"},{"key":"57458","doi-asserted-by":"crossref","unstructured":"Locatelli F, N\u00f6llke P, Zecca M. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS\/ EBMT trial. Blood. 2005; 105(1):410-419.","DOI":"10.1182\/blood-2004-05-1944"},{"key":"57459","doi-asserted-by":"crossref","unstructured":"Yabe M, Ohtsuka Y, Watanabe K. Transplantation for juvenile myelomonocytic leukemia: a retrospective study of 30 children treated with a regimen of busulfan, fludarabine, and melphalan. Int J Hematol. 2015; 101(2):184-190.","DOI":"10.1007\/s12185-014-1715-7"},{"key":"57460","doi-asserted-by":"crossref","unstructured":"Dvorak CC, Satwani P, Stieglitz E. Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: a Children\u2019s Oncology Group study. Pediatr Blood Cancer. 2018; 65(7):e27034.","DOI":"10.1002\/pbc.27034"},{"key":"57461","doi-asserted-by":"crossref","unstructured":"Mayerhofer C, Niemeyer CM, Flotho C. Current treatment of juvenile myelomonocytic leukemia. J Clin Med. 2021; 10(14):3084.","DOI":"10.3390\/jcm10143084"},{"key":"57462","doi-asserted-by":"crossref","unstructured":"Lipka DB, Witte T, Toth R. RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia. Nat Commun. 2017; 8(1):2126.","DOI":"10.1038\/s41467-017-02177-w"},{"key":"57463","doi-asserted-by":"crossref","unstructured":"Calvo KR, Price S, Braylan RC. JMML and RALD (Rasassociated autoimmune leukoproliferative disorder): common genetic etiology yet clinically distinct entities. Blood. 2015; 125(18):2753-2758.","DOI":"10.1182\/blood-2014-11-567917"},{"key":"57464","doi-asserted-by":"crossref","unstructured":"Hecht A, Meyer JA, Behnert A. Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia. Haematologica. 2022; 107(1):178-186.","DOI":"10.3324\/haematol.2020.270595"},{"key":"57465","doi-asserted-by":"crossref","unstructured":"Mariani RA, Jennings L, Zhang S, Bhat R, Gong S. Morphologic and immunophenotypic differences in juvenile myelomonocytic leukemias with CBL and other canonical RAS-pathway gene mutations: a single institutional experience. J Pediatr Hematol Oncol. 2021; 43(6):e819-e825.","DOI":"10.1097\/MPH.0000000000002149"},{"key":"57466","doi-asserted-by":"crossref","unstructured":"Niemeyer CM, Flotho C, Lipka DB. Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial. Blood Adv. 2021; 5(14):2901-2908.","DOI":"10.1182\/bloodadvances.2020004144"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.282805\/75914","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2023.282805\/76544","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11187\/75914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:04:37Z","timestamp":1794045877000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2023.282805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,3]]},"references-count":40,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2023.282805","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,3]]}}}